WILLIAM CONWAY: Open Payments
NPI 1558811380 · MASSILLON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,167 in 212 payments from 50 companies in 2025. Trend: 2023 $3,172 · 2024 $3,548 · 2025 $4,167
Food & beverage: $3,981Education: $200
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 14 | $273 |
| Daiichi Sankyo Inc. | 15 | $231 |
| Novartis Pharmaceuticals Corporation | 11 | $230 |
| PFIZER INC. | 14 | $223 |
| AstraZeneca Pharmaceuticals LP | 10 | $214 |
| Janssen Biotech, Inc. | 11 | $207 |
| Incyte Corporation | 11 | $206 |
| E.R. Squibb & Sons, L.L.C. | 11 | $201 |
| SEAGEN INC. | 2 | $174 |
| Eisai Inc. | 10 | $172 |
Products named: KEYTRUDA, Lenvima, ENHERTU, OPDIVO, Vyloy, JAKAFI, REBLOZYL, Fabhalta.
Industry payments across OH — which companies pay providers there.
